Resonac Holdings stock
4004.TJPXResonac Holdings Corporation, Basic MaterialsISIN JP3368000000
46Score 46 out of 100, Weak
Price and trend
66 / 100
Price history
+137% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 1.4% below it.
Since August 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 56).
The price is 28% below its 52-week high. Largest decline in 20 years: 81% (January 2007 to July 2016).
Chart figures for advanced users
- SMA 50$91.62
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$88.93
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)56
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$34.98
- The lowest closing price of the last twelve months.
- Resistance$121.79
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Resonac Holdings Corporation belongs to the Chemicals industry (Japan) and, with a market value of $16.64B, is number 9 of 44 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $8.44B (down 3.2% year on year) and earnings of $181.79M (down 60.5%).
- For fiscal 2026, analysts expect on average revenue of $7.59B (down 10.1%) and adjusted earnings per share of $3.66 (up 275.7%).
Show more
- MEQIRI Score 46 out of 100 (Weak): rank 352 of 461 in Basic Materials, median 57.
- The P/E is 49 (Chemicals median 19.2, own median of recent years 11.3).
- Our model puts fair value at $120.90, with the price 27% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Analysts expect strong earnings growthUp 29.7% a year through 2028 (estimates from 12 analysts).
Weaknesses
- Richly valuedP/E 49, Chemicals median 19.2, own median 11.3.Valuation 49
- DilutionShare count up 24% since 2020.Capital allocation 27
- Volatile share priceVolatility 74% a year over the last 12 months.Stability 46
The score is held back by profitability and capital allocation.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 45 to 46.
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Modestly undervaluedClosing price of 12 Nov 2026, used by the daily score.
In our model the price counts as cheap below $80.60 and expensive above $241.80 (uncertainty very high, based on the price swings of the past year).
The two parts of the fair value come to $207.37 (cash-flow model) and $34.43 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 6.1%. At 7.1% the fair value would be $101.38, at 5.1% it would be $150.39.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (19.2).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue rose 1.3% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 24%, operating 4%, net 2%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 15 Feb 2027in 94 days
- Last reported
- 11 Nov 2026EPS reported $1.58
Analyst estimates
Earnings estimates have barely changed since 24 Oct 2026.
- Earnings per share
- $3.66−0.1%
- Revenue
- $7.59B+0.6%
- Earnings per share
- $5.45+1.2%
- Revenue
- $8.08B+0.1%
MEQIRI has stored the estimates since 24 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Resonac Holdings
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 46
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals
The next larger and next smaller companies by market value
- Ningxia Baofeng Energy Group600989.SS $22.5B72
- DuPont de NemoursDD $20.5B50
- Rongsheng Petrochemical002493.SZ $17.03B51
- Hengli Petrochemical600346.SS $16.94B50
- Zangge Mining000408.SZ $15.19B71
- Zhejiang Juhua600160.SS $12.86B62
- LG Chem051910.KS $12.78B39
- Formosa Chemicals & Fibre1326.TW $12.68B52
ETFs that hold Resonac Holdings
Held by 85 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Amundi MSCI New Energy UCITS ETF DistLYM9 | 1.45% | 0.60% | €976.93M |
| Xtrackers Future Mobility UCITS ETF 1CXMOV | 0.60% | 0.35% | €167.19M |
| Xtrackers MSCI World Materials UCITS ETF 1CXDWM | 0.42% | 0.25% | €720.77M |
Show 5 more
| Deka MSCI Japan UCITS ETFEL44 | 0.33% | 0.52% | €83.83M |
| Xtrackers MSCI Japan Screened UCITS ETF 1DXDNY | 0.31% | 0.15% | €457.17M |
| Amundi MSCI Smart Mobility UCITS ETF AccELCR | 0.31% | 0.45% | €144.9M |
| Vanguard FTSE Japan UCITS ETF EUR Hedged AccumulatingVJPE | 0.28% | 0.13% | €4.58B |
| Amundi Prime Japan UCITS ETF DR (C)PRAJ | 0.25% | 0.05% | €4.34B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 13 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ¥159.70)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 16 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.